06
Top Organizations
05
Top 20 Organizations EU Scientific Vacancies
In 2023, notable strategic shifts among leading firms are reshaping the employment dynamics within the biotechnology industry. One such significant player, BioNTech, retains a considerable share of the market, contributing to 25% of the total vacancies within the top 20 companies. However, a noteworthy development is the 21.7% reduction in scientific vacancies within BioNTech. This adjustment is in tandem with the company’s revised revenue forecast, reflecting a response to decreased demand for its COVID-19 vaccine. Consequently, BioNTech is reallocating resources, particularly in its R&D budget, redirecting focus towards its promising oncology pipeline. Contrary to this trend, Genmab, headquartered in Denmark, is defying industry norms by witnessing a remarkable 40.3% surge in job openings. This surge not only enhances Genmab’s market presence but also positions it as a notable player in the evolving biotechnology landscape. Concurrently, companies like Amgen, Grifols, and PSC Biotech are expanding their market shares, each approaching a 10% share. These developments signify strategic growth initiatives and suggest a more assertive approach in talent acquisition. However, not all companies are experiencing positive trends. Miltenyi Biotec and Biogen find themselves under market pressures, encountering declines of 63.1% and 83.1%, respectively, in job openings. These contrasting trajectories underscore the diverse challenges faced by companies within the biotechnology sector. Amidst these nuanced shifts, the industry is undergoing a broader consolidation. The concentration of market share within the top five companies has increased to 57%, up significantly from 34% the previous year. This underscores a fiercely competitive marketplace where a handful of prominent players are seemingly gaining ground, potentially at the expense of smaller entities. The intricate interplay of these market forces highlights the evolving and complex nature of the biotech sector’s hiring landscape, which is reflective of the dynamic nature of the industry.
YoY%
Organization
HQ
2022 2023*
-21.7%
BioNTech
589
Germany
752
Genmab
40.3%
260
Denmark
185
Amgen
-11.0%
193
USA
217
-5.7%
Grifols
173
Spain
184
-36.8%
PSC Biotech
156
USA
247
Galapagos
27.9%
141
Belgium
110
CureVac
5.6%
131
Germany
124
-63.1%
Miltenyi Biotec
119
Germany
322
bioMerieux
-27.3%
98
France
135
BeiGene
25.1%
94
USA
75
AGC Biologics
-58.3%
91
USA
217
14.5%
70
Belgium
61
Argenx
-12.0%
Gyros Protein
55
Sweden
62
Cytiva
-52.8%
49
USA
104
Euroimmun
-12.7%
44
Germany
50
-31.0%
34
Germany
49
ProBioGen
-11.5%
33
Sweden
37
Olink
-34.5%
26
USA
40
Bio-Rad
-57.6%
23
Denmark
54
Novozymes
-83.1%
20
USA
116
Biogen
Source: Vacancysoft Analytics
Fig. 07
2023* - Estimation
Made with FlippingBook - Share PDF online